Autoreactivity vs autoimmunity: characteristics of autoantigen-specific CD4 T-cells in rheumatoid arthritis and health. - Report - MDSpire

Distinguishing Autoreactivity from Autoimmunity: Features of CD4 T-cells Specific to Autoantigens in Rheumatoid Arthritis and Healthy Individuals.

  • By

  • James A. Stanway

  • Daniel Peters

  • Helen Waller

  • Jeremy Lakey

  • Henrique De Paula Lemos

  • Kristian Williams

  • Abbie Degnan

  • Julie Diboll

  • Abdul Mannan Baru

  • David Tough

  • Arthur G. Pratt

  • Catharien M.U. Hilkens

  • Amy E. Anderson

  • John D. Isaacs

  • June 1, 2026

Share

Distinguishing Autoreactivity from Autoimmunity in Rheumatoid Arthritis

Overview

This study investigates the characteristics of CD4 T-cells specific to autoantigens in individuals with rheumatoid arthritis (RA) compared to healthy individuals.

Background

Rheumatoid arthritis (RA) is a significant autoimmune disorder characterized by the presence of various autoantibodies, including anti-modified protein antibodies (AMPAs). Understanding the distinctions between autoreactivity and autoimmunity is important.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • CD4 T-cells specific to autoantigens exhibit distinct features in RA compared to healthy individuals.
  • Anti-modified protein antibodies (AMPAs) can be detected years before the clinical onset of RA.
  • Differences in T-cell responses may help differentiate between autoreactivity and pathogenic autoimmunity.
  • Understanding T-cell subsets may provide insights into autoimmunity in RA.
  • Early identification of autoantibodies is linked to disease progression.

Clinical Implications

The findings may aid in the diagnosis of RA.

Conclusion

This study contributes to the understanding of the immunological landscape in rheumatoid arthritis.

Related Resources & Content

  1. Arthritis & Rheumatology, 2023 -- The Role of IgM Anti-acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis
  2. Frontiers in Immunology, 2026 -- Soluble IL-2 receptor and memory Treg profiles differentiate early rheumatoid arthritis from undifferentiated arthritis at initial presentation
  3. Clinical Rheumatology, 2024 -- Intersecting Pathways of Autoimmune Thyroid Disease and Rheumatoid Arthritis
  4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update - PubMed
  5. Nature Reviews Rheumatology, 2025 -- Two subsets of TPH cells with distinct functions in RA
  6. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis
  7. Frontiers in Immunology — Expression characteristics of C-reactive protein in autoimmune diseases and their complications
  8. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update - PubMed
  9. Two subsets of TPH cells with distinct functions in RA | Nature Reviews Rheumatology
  10. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis

Original Source(s)

Related Content